Showing results (171-180 of 198) with videos related to
Sort By:
Pageof 20
Journal of Hepatology|September 17, 1999
Prevalence and risk factors of bacteriuria in cirrhotic patients: a prospective case-control multicenter study in 244 patientsJ F Cadranel, J Denis, A Pauwels, et al.Journal of Dairy Science|August 29, 2023
The effect of progesterone concentrations during superovulation of Holstein heifers in a randomized trialJ C S Marques, J P O Maciel, J Denis-Robichaud, et al.Endoscopy|October 31, 2012
Epidemiological and prognostic factors involved in upper gastrointestinal bleeding: results of a French prospective multicenter studyS Nahon, H Hagège, J P Latrive, et al.Journal of Hepatology|October 9, 1998
Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trialJ D Grangé, D Roulot, G Pelletier, et al.Journal of Cardiovascular Pharmacology|May 1, 1997
Assessment of antihypertensive effect by blood pressure monitoring: applications to bisoprolol and lisinopril in a double-blind studyB Vaïsse, D Herpin, R Asmar, et al.Alimentary Pharmacology & Therapeutics|October 20, 2007
Coeliac disease in chronic hepatitis C: a French multicentre prospective studyT Thevenot, J Denis, V Jouannaud, et al.Journal of Dairy Science|March 26, 2026
Effect of GnRH administration at the supposed time of artificial insemination on LH and prostaglandin F2α metabolite profiles in lactating Holstein cowsR S Conceicao, J C S Marques, S Moore, et al.Microbiology Spectrum|March 26, 2025
Identification of Toxoplasma gondii antigenic proteins using an in vivo approach and in silico investigation of their polymorphismJ Denis, C Gommenginger, L Beal, et al.Theriogenology|August 2, 2025
Tail chalk improved detection of true estrus alerts from an automated activity monitor system in a cohort studyJ C S Marques, T A Burnett, J Denis-Robichaud, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 17, 2009
Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumorsAlain C Mita, Louis J Denis, Eric K Rowinsky, et al.Pageof 20